Indications for, and use of, cytotoxic agents in SLE

Bailliere's Clinical Rheumatology

Volumn 12, Issue 3, 1998, Pages 511-527

  Klippel, J H ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Azathioprine; Cyclophosphamide; Immune suppression; Methotrexate

Indexed keywords

ADENOSINE DERIVATIVE; AZATHIOPRINE; CHLORAMBUCIL; CHLORMETHINE; CLADRIBINE; CORTICOSTEROID; CREATININE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTOTOXIC AGENT; FLUDARABINE; FLUDARABINE PHOSPHATE; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ARTICLE; BLADDER DISEASE; CARCINOMA; CLINICAL TRIAL; GASTROINTESTINAL DISEASE; HEART DISEASE; HEMATOLOGIC DISEASE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; LUNG DISEASE; META ANALYSIS; METABOLIC DISORDER; NAUSEA; NEUROLOGIC DISEASE; PRIORITY JOURNAL; REMISSION; SKIN DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; VOMITING;

EID: 0031768794     PISSN: 09503579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-3579(98)80033-2     Document Type: Article

References (54)

1. Abud-Mendoza C Sturbaum AK Vazquez-Compean R Gonzalez-Amaro R Methotrexate therapy in childhood systemic lupus erythematosus Journal of Rheumatology 20 1993 731 733
2. Appel GB Valeri A The course and treatment of lupus nephritis Annual Review of Medicine 45 1994 525 536
3. Austin HA Klippel JH Balow JE Therapy of lupus nephritis: controlled trial of prednisone and cytotoxic drugs New England Journal of Medicine 314 1986 614 619
4. (abstract) Austin HA Vaughan EM Boumpas DT Lupus membranous nephropathy: controlled trial of prednisone, pulse cyclophosphamide, and cyclosporine Journal of the American Society of Nephrology 7 1996 1328
5. Balow JE Austin HA Muenz LR Effect of treatment on the evolution of renal abnormalities in lupus nephritis New England Journal of Medicine 311 1984 491 495
6. Bansal VK Beto JA Treatment of lupus nephritis: a meta-analysis of clinical trials American Journal of Kidney Diseases 29 1997 193 199
7. Belmont HM Storch M Buyon J Abramson S Intravenous cyclophosphamide treatment: efficacy in steroid unresponsive lupus nephritis Lupus 4 1995 104 108
8. Boumpas DT Barez S Klippel JH Balow JE Intermittent cyclophosphamide for the treatment of autoimmune thrombocytopenia in systemic lupus erythematosus Annals of Internal Medicine 112 1990 674 677
9. Boumpas DT Patronas N Dalakas MC Acute transverse myelitis in systemic lupus erythematosus: magnetic resonance imaging and review of the literature Journal of Rheumatology 17 1990 89 92
10. Boumpas DT Austin HA Vaughan EM Severe lupus nephritis: controlled trial of pulse methylprednisolone versus two different regimens of pulse cyclophosphamide Lancet 340 1992 741 744
11. Boumpas DT Austin HA Vaughan EM Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide Annals of Internal Medicine 119 1993 366 369
12. Burt RK BMT for severe autoimmune diseases: an idea whose time has come Oncology 11 1997 1001 1014
13. Caccavo D Lagana B Mitterhofer AP Long-term treatment of systemic lupus erythematosus with cyclosporin A Arthritis and Rheumatism 40 1997 27 35
14. Cannon GW Jackson CG Samuelson CO Chlorambucil therapy in rheumatoid arthritis: clinical experience in 28 patients and literature review Seminars in Arthritis and Rheumatism 15 1985 106 118
15. Chan KF Boey ML Transverse myelopathy in SLE: clinical features and functional outcomes Lupus 5 1996 294 299
16. Chan TM Li FK Wong RW Sequential therapy for diffuse proliferative and membranous lupus nephritis: cyclophosphamide and prednisolone followed by azathioprine and prednisolone Nephron 71 1995 321 327
17. Ciruelo E de la Cruz J Lopez I Gomez-Reino JJ Cumulative rate of relapse of lupus nephritis after successful treatment with cyclophosphamide Arthritis and Rheumatism 39 1996 2028 2034
18. Conlon PJ Fischer CA Levesque MC Clinical, biochemical and pathological predictors of poor response to intravenous cyclophosphamide in patients with proliferative lupus nephritis Clinical Nephrology 46 1996 170 175
19. D'Cruz D Cuadrado MJ Mujic F Immunosuppressive therapy in lupus nephritis Clinical and Experimental Rheumatology 15 1997 275 282
20. Davis JC Austin HA Boumpas D A pilot study of 2-chloro-2′-deoxyadenosine in the treatment of glomerulonephritis in patients with systemic lupus erythematosus Arthritis and Rheumatism 41 1998 335 343
21. Dawisha SM Yarboro CH Vaughan EM Outpatient monthly oral bolus cyclophosphamide therapy in systemic lupus erythematosus Journal of Rheumatology 23 1996 212 213
22. Dooley MA Hogan S Jennette C Falk R Cyclophosphamide therapy for lupus nephritis: poor renal survival in black Americans Kidney International 51 1997 1188 1195
23. (abstract) Dooley MA Nachman PH Satterly KK Mycophenylate mofetil therapy in resistant or relapsing diffuse proliferative lupus nephritis (SLE-DPGN) following cyclophosphamide (CyP) therapy Arthritis and Rheumatism 40 1997 S58
24. Eiser AR Shanies HM Treatment of lupus interstitial lung disease with intravenous cyclophosphamide Arthritis and Rheumatism 37 1994 428 431
25. Felson DT Anderson J Evidence for the superiority of immunosuppressive drugs and prednisone over prednisone alone in lupus nephritis. Results of a pooled analysis New England Journal of Medicine 311 1984 1528 1533
26. Fukuda M Kamiyama Y Kawahara K The favourable effect of cyclophosphamide pulse therapy in the treatment of massive pulmonary haemorrhage in systemic lupus erythematosus European Journal of Pediatrics 153 1994 167 170
27. Gansauge S Breitbart A Rinaldi N Schwarz-Eywill M Methotrexate in patients with moderate systemic lupus erythematosus (exclusion of renal and central nervous system disease) Annals of the Rheumatic Diseases 56 1997 382 385
28. Gourley MF Austin HA Scott D Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial Annals of Internal Medicine 125 1996 549 557
29. Kono DH Klashman DJ Gilbert RC Successful IV pulse cyclophosphamide in refractory PM in 3 patients with SLE Journal of Rheumatology 17 1990 982 983
30. Liang TJ Gastrointestinal vasculitis and pneumatosis intestinalis due to systemic lupus erythematosus: successful treatment with pulse intravenous cyclophosphamide American Journal of Medicine 85 1988 555 558
31. Manger K Kalden JR Manger B Cyclosporin A in the treatment of systemic lupus erythematosus: results of an open clinical study British Journal of Rheumatology 35 1996 669 675
32. Martin-Suarez I D'Cruz D Mansoor M Immunosuppressive treatment in severe connective tissue diseases: effects of low dose intravenous cyclophosphamide Annals of the Rheumatic Diseases 56 1997 481 487
33. Martinez-Taboada VM Alonso RB Armona J Mononeuritis multiplex in systemic lupus erythematosus: response to pulse intravenous cyclophosphamide Lupus 5 1996 74 76
34. Masala A Faedda R Alagna S Use of testosterone to prevent cyclophosphamide-induced azoospermia Annals of Internal Medicine 126 1997 292 295
35. Neuwelt CM Lacks S Kaye BR Role of intravenous cyclophosphamide in the treatment of severe neuropsychiatric systemic lupus erythematosus American Journal of Medicine 98 1995 32 41
36. Nyberg G Eriksson O Westberg NG Increased incidence of cervical atypia in women with systemic lupus erythematosus treated with chemotherapy Arthritis and Rheumatism 24 1981 648 650
37. Ognibene FP Shelhammer JH Hoffman GS Pneumocystis carinii pneumonia: a major complication of immunosuppressive therapy in patient with Wegener's granulomatosis American Journal of Respiratory Critical Care Medicine 151 1995 795 799
38. (abstract) Pando JA Gourley MF Boumpas DT Risks of malignancy in patients with lupus nephritis treated with bolus cyclophosphamide Arthritis and Rheumatism 37 1994 S179
39. Ponticelli C Zuccgelli P Passerini P A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy Kidney International 48 1995 1600 1604
40. Pryor BD Bologna SG Kahl LE Risk factors for serious infection during treatment with cyclophosphamide and high-dose corticosteroids for systemic lupus erythematosus Arthritis and Rheumatism 39 1996 1475 1482
41. Radhakrishnan J Kunis CL D'Agati V Cyclosporine treatment of lupus membranous nephropathy Clinical Nephrology 42 1994 147 154
42. Radis CD Kahl LE Baker GL Effects of cyclophosphamide on the development of malignancy and on long-term survival of patients with rheumatoid arthritis Arthritis and Rheumatism 38 1996 1120 1127
43. Ramsey-Goldman R Achilling E Immunosuppressive drug use during pregnancy Rheumatic Disease Clinics of North America 23 1997 149 167
44. Reichert LJ Huysmans FT Assmann K Preserving renal function in patients with membranous nephropathy: daily oral chlorambucil compared with intermittent monthly pulses of cyclophosphamide Annals of Internal Medicine 121 1994 328 333
45. Rosenbaum JT Simpson J Neuwelt CM Successful treatment of optic neuropathy in association with systemic lupus erythematosus using intravenous cyclophosphamide British Journal of Ophthalmology 81 1997 130 132
46. (abstract) Schroeder JO Schwab U Zeuner R Plasmapheresis and subsequent pulse cyclophosphamide in severe systemic lupus erythematosus. Preliminary results of the LPSG-Trial Arthritis and Rheumatism 40 1997 S324
47. Silverman E What's new in the treatment of pediatric SLE Journal of Rheumatology 23 1996 1657 1660
48. Singh G Fries JF Spitz P Williams CA Toxic effects of azathioprine in rheumatoid arthritis. A national post-marketing perspective Arthritis and Rheumatism 32 1989 837 843
49. Snaith MI Holt JM Oliver DO Dunnill MS Treatment of patients with systemic lupus erythematosus including nephritis with chlorambucil British Medical Journal 2 1973 197 201
50. Talar-Williams C Hijazi YM Walther MM Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegner granulomatosis Annals of Internal Medicine 124 1996 477 484
51. Wallace DJ Metzger AL Successful use of nitrogen mustard for cyclophosphamide resistant diffuse proliferative lupus glomerulonephritis: report of 2 cases Journal of Rheumatology 22 1995 801 802
52. Walport MJ Hubbard WN Hughes GRV Reversal of aplastic anemia secondary to systemic lupus erythematosus by high-dose cyclophosphamide British Medical Journal 285 1982 769 770
53. Walz LeBlanc BA Dagenais P Urowitz MB Gladman DD Methotrexate in systemic lupus erythematosus Journal of Rheumatology 21 1994 836 838
54. Wise CM Vuyyuru S Roberts WN Methotrexate in nonrenal lupus and undifferentiated connective tissue disease—a review of 36 patients Journal of Rheumatology 23 1996 1005 1010